Interested in Gold Updates?
Receive the latest updates on the gold and silver markets.
...
Health Technology » Pharmaceuticals Other
| symbol | company | %chng | last | %short | avg$volume | |
|---|---|---|---|---|---|---|
| VRX | Valeant Pharmaceuticals International, Inc. | -1.89% | 27.00 | 14.1% | $158.87m | |
| HZNP | Horizon Therapeutics Plc | -0.95% | 80.43 | 5.6% | $158.03m | |
| ACRS | Aclaris Therapeutics, Inc. | -4.57% | 17.97 | 5.3% | $136.21m | |
| CTLT | Catalent, Inc. | -0.13% | 119.67 | 2.1% | $103.91m | |
| BHC | Bausch Health Cos., Inc. | -1.89% | 27.00 | 0.0% | $102.08m | |
| JAZZ | Jazz Pharmaceuticals Plc | 0.17% | 167.29 | 2.4% | $86.77m | |
| ACST | Acasti Pharma, Inc. | 18.64% | 0.76 | 0.2% | $71.66m | |
| ISR | IsoRay, Inc. | 2.08% | 2.46 | 2.5% | $65.10m | |
| UTHR | United Therapeutics Corp. | -0.26% | 171.17 | 14.1% | $64.58m | |
| AMRN | Amarin Corp. Plc | -1.43% | 6.20 | 1.5% | $50.03m | |
| PRGO | Perrigo Co. Plc | -0.44% | 43.28 | 6.8% | $49.66m | |
| GWPH | GW Pharmaceuticals Plc | 0.02% | 136.93 | 6.1% | $48.40m | |
| SAGE | SAGE Therapeutics, Inc. | 1.85% | 91.21 | 7.6% | $46.77m | |
| ARGX | argenx SE | 6.40% | 305.36 | 0.0% | $43.44m | |
| ICLR | ICON plc | 2.72% | 220.96 | 4.2% | $41.59m |
Company Profile
Cassava Sciences, Inc. engages in the development of novel drugs and diagnostics. It focuses on developing product candidates intended for the treatment of Alzheimer’s disease, including PTI-125 and PTI-125Dx. The company was founded by Remi Barbier and Barry M. Sherman in May 1998 and is headquartered in Austin, TX.